Does germline BRCA 1/2 mutation status impact your use of OncoType Dx for early stage ER positive breast cancers in post-menopausal women?

Germline BRCA1/2 associated tumors tend to have higher grade and higher Oncotype recurrence score (RS). One of the reported studies out of MSKCC showed higher median Recurrence Score (RS) for mutation carriers versus controls (24 vs 16; P < .0001). Since RS is both prognostic and predictive, BRCA1/2...